Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51.9M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
801K
-
Shares change
-
-156K
-
Total reported value, excl. options
-
$3.88M
-
Value change
-
-$429K
-
Number of buys
-
5
-
Number of sells
-
-6
-
Price
-
$4.85
Significant Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q4 2019
15 filings reported holding DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value as of Q4 2019.
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 801K shares
of 51.9M outstanding shares and own 1.54% of the company stock.
Largest 10 shareholders include Manatuck Hill Partners, LLC (272K shares), Granite Point Capital Management, L.P. (227K shares), Worth Venture Partners, LLC (122K shares), VANGUARD GROUP INC (81.1K shares), MILLENNIUM MANAGEMENT LLC (33K shares), BlackRock Inc. (32.1K shares), GEODE CAPITAL MANAGEMENT, LLC (17.6K shares), BLAIR WILLIAM & CO/IL (10K shares), Federation des caisses Desjardins du Quebec (5.8K shares), and Patriot Financial Group Insurance Agency, LLC (2.75K shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.